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Multiple abnormalities have been reported in the setting ofhuman heart failure.
It is unclear whether detected changes reflect adaptive alterations in myocardi-
um subjected to increased and sustained hemodynamic overload or are patho-
genic to the disease process. As a result of the observation that the primary
defect in heart failure is decreased pump function, investigators have concen-
trated their efforts on determining systolic [Ca2+], as a logical corollary and a
causative mechanism for contractile dysfunction. A simple cause and effect
relationship has therefore been proposed with regard to contractile dysfunction
and [Ca2+]1. Yet some investigators have found no difference in peak systolic
[Ca2+]. between failing and non-failing human myocardium, whereas others
have Pound peak [Ca2+], to be significantly reduced in failing hearts. Resting
calcium concentrations have been reported either to be elevated in failing
human myocardium or not different from non-failing human myocardium.
Investigators should now appreciate that the force-calcium relationship is not a
simple relationship. One must take into account the prolonged time course and
slowed mobilization of [Ca2+]1 as opposed to simply peak [Ca2+].. When put in
perspective ofmechanisms and determinants oftheCa2+-force rAationship, we
begin to realize that failing human myocardium has the "potential" to generate
normal levels of force. Only when stressed by [Ca2+]. overload and/or frequen-
cy perturbation does myocardium from patients witi end-stage heart disease
demonstrate contractile failure. Although [Ca2+], availability and mobilization
are likely to play a role in the systolic as well as diastolic dysfunction reported
in human heart failure, it is likely that other mechanisms are involved as well
(e.g., myocardial energetics). Myocardial energetics is directly related to[Ca2+]I
and mobilization in failing human myocardium, because metabolites, e.g.,ADP,
inhibit pumps, such as sarcoplasmic reticulum Ca2+ ATPase activity. We there-
fore conclude that there is a role for intracellular calcium mobilization and
myocardial energetics forsystolic and diastolic dysfunction seen in human heart
failure.
With the development of cardiac transplantation programs, human myocardium has
become available for study. However, studies utilizing human myocardium harvested at
the time of cardiac transplantation have only afforded an ice-pick view of an end-stage
process. Furthermore, studies are flawed because the etiologies often differ or are
unknown, the duration ofheartfailure varies betweenpatients and there arediffering phar-
macologic therapies being received by individual patients. Most concerning is that there
are no true "normal" hearts available for study and comparison. Despite these limitations,
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Cardiovascular Disease and Muscle Research Laboratories, Harvard Medical School, Building B1,
Room 146, 220 Longwood Avenue, Boston, MA02115. Tel: (617) 432-0306; Fax: (617) 432-0316;
E-mail: gwathmey@warren.med.harvard.edu.
bAbbreviations: DPBA, 12-deoxyphorbol-13-isobutyrate-20-acetate; ICa' calcium channel current
density; SR, sarcoplasmic reticulum; DCM, dilated cardiomyopathy.
247Liao et al.: [Ca2+Ji and heartfailure
studies using human myocardium have yielded important new insights into cellularmech-
anisms ofthe end-stage process.
There is a relationship between the force of myocardial contraction and calcium. A
simple cause and effect relationship has, therefore, been proposed with regard to contrac-
tile dysfunction and [Ca2+]i in failing human hearts (Figure 1). Other proposed mecha-
nisms involved in contractile failure include: 1) down-regulation of ,3-receptors; 2)
decreased myofilament calcium responsiveness; 3) decreased myofibrillar Mg ATPase
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Figure 1. Schematic ofcalcium movements within in cardiocyte. When the sarcolemma is depo-
larized, a small amount of Ca2+ enters through voltage-dependent calcium channels. This small
amount ofcalcium induces the release ofa much larger amount ofCa2+from the sarcoplasmic retic-
ulum (Ca2+-induced calcium release) that then binds to the myofilaments resulting in contractile
activation. Relaxation occurs when the calcium is resequestered into the SR and removed from the
cytosol via the Na-Ca exchange and sarcolemmal Ca2+ ATPase. Mitochondria serve as calcium
stores and buffers. Ca = calcium, EC = extracellular space, SR = sarcoplasmic reticulum. ICa =
transsarcolemmal calciumcurrent. By performing skinned fiberexperiments wherethe sarcolemma,
SR and mitochondria are destroyed, force can be plotted vs. known bath calcium concentrations
(pCa = -log [Ca2+]) and myofilament calcium responsiveness directly studied. The force-[Ca2+]
relationship is fit to the modified Hill relationship.
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activity and decreased myofibrillar protein content; and/or 4) decreased energy supply.
Experimental studies on non-failing and diseased human hearts have supported some of
these hypotheses andrejected others. The mechanism ofcontractile failure seen with heart
failure, therefore, remains elusive.
5-RECEPTOR FUNCTION
It has been clearly demonstrated thatP1 receptors are down-regulated while 12 recep-
tor number is unchanged in the setting of heart failure [1]. As demonstrated in Figure 2,
inotropic response to increasing concentrations ofisoproterenol, a non-selective 1-recep-
tor agonist, is diminished in right ventricular trabeculae cameae isolated from failing
human hearts (open triangles) compared tomuscles from non-failing hearts (open circles).
However, addition of forskolin, which directly activates adenylate cyclase coupling 13-
receptors via G proteins to intracellular ATP hydrolysis, produces similar contractile
responses in muscles from failing and non-failing human hearts. These data suggest that
adenylate cyclase activity is intact in failing human hearts.
It has been accepted that the changes in ,B-receptor number and function is not path-
ogenic in the disease process andmorelikely reflect adaptiveresponses ofthe failing heart
to excess catecholamine stimulation [1]. This premise is supported by studies with 1-
receptor antagonists, which, despite dramatic improvement in cardiac function, result in
only partial recovery of ,3-receptor numbers [2]. Furthermore, in a study using carvedilol,
which does not affect 13-receptor number, there was a significant improvement in cardiac
function despite an unchanged receptor number [3]. This would appear to uncouple the
number of 1-receptors as being causally related to contractile failure.
MYOFILAMENT CALCIUM SENSITIVITY AND ATPase ACTIVITY
A decrease in maximal force or myofilament calcium responsiveness (i.e., a change
in cooperativity or slope of the force calcium relationship or calcium concentration
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Figure 2. Isolated trabeculae carneae from non-failing and failing human hearts were
stretched to the peak of the active tension curve and electrically stimulated to contract.
Response to increasing concentrations of isoproterenol and forkolin on isometric twitch force
expressed as a percent of maximal twitch response to high [Ca2+]0. ISO = isoproterenol, M =
moles/liter; percent MAX Ca++ = twitch force expressed as a percent of maximal response to high
calcium concentration the bath. A = myopathic human muscles. o = control human muscles.
249Liao et al.: [Ca2+Ji and heartfailure
required for 50 percent contractile activation ([Ca2+]50%) has been proposed as explana-
tion for the decreased contractile performance of failing human hearts. Maximal force
developed by chemically skinned trabeculae carneae of patients with heart failure has
been shown to be similar to that ofnon-failing myocardium [1, 5]. Figure 3 demonstrates
maximal calcium-activated force, Hill coefficients and calcium required for 50 percent
contractile activation in non-failing and myopathic fibers using two techniques, i.e.,
steady-state tetani in intact muscle preparations and saponin skinned fibers. Figure 4
demonstrates a non-signal averaged force and calcium trace of a twitch and steady-state
activation. The Ca2+sensitivity ofthe myofilaments in chemically skinned [4-6] and intact
fibers [4] from failing human hearts are comparable to that of non-failing myocardium.
As demonstrated in Figure 5, increasing peak [Ca2+]i results in contractile activation
that is similar for failing (open triangles) and non-failing human myocardium (open cir-
cles) when agents like acetylstrophanthidin, a digitalis-like compound, and DPI 201-206,
a sodium channel agonist and calcium sensitizer, are applied. Both agents increase intra-
cellular calcium via sodium-calcium exchange. These experiments support the idea that
changes in myofilament calcium responsiveness do not play a direct role in contractile
failure. Furthermore, myofilament responsiveness to changes in[Ca2+]i is similar for fail-
ing and non-failing human myocardium.
Despite similar force-pCarelationships, there are, nevertheless, changes at the level of
the thin myofilaments.. Hajar et al. first demonstrated that changes at the level of the thin
myofilaments may at times only be detected when agents targeted at the level of the thin
myofilaments are applied [5]. Addition of 1 FM DPI 201-106 resulted in a 0.2 pCa unit
shift in the force-pCa relationship in myopathic human myocardium with no change in
fibers from non-failing hearts [5]. It is interesting thatmyopathic human myocardium tend-
ed to have a slightly higher Hill coefficient that tended to increase in the presence of DPI
201-106 (not significant). Addition of 12-deoxyphorbol-13-isobutyrate-20-acetate
(DPBA)b, which simulates protein kinase C activity, affected the Hill parameters different-
ly in non-failing and failing human myocardium [7]. The [Ca2+]j required for 50 percent
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Figure 3. Intact and skinned muscle fibers from non-failing and failing human hearts. Intact
muscles were tetanized by stimulating at 50 Hz with a long pulse duration. Fibers from the same
hearts were chemically skinned with saponin. Maximal calcium-activated force was measured at
pCa = 4; g/mm2 =grams/millimeter2; iM = micromoles of calcium.
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Figure 4. Non-signal averaged force and calcium trace ofa twitch and steady-state activation
in human trabeculae. g/mm2 = grams/millimeter2; L/LmA = -log nanoamperes/-log maximal
nanoamperes from the phototmultiplier tube (see Ref. 14 for details).
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Figure 5. Isolated trabeculae carneae from non-failing and failing human hearts were
stretched to the peak of the active tension curve and electrically stimulated to contract.
Response to increasing concentrations ofacetylstrophanthidin and DPI 201-106 on isometric twitch
force expressed as a percent of maximal twitch response to high [Ca2+]0; M = moles/liter; percent
MAX Ca++ = twitch force expressed as a percent of maximal response to high calcium concentra-
tion in the bath; A = myopathic human muscles; o = control human muscles.
activation of the myofilaments in steady-state force-calcium relationships obtained with
tetani was decreased by 0.09 pCa units in non-failing myocardium vs. 0.21 pCa units for
failing myocardium. The Hill coefficients for steady-state contractions were decreased by
2.4 units in non-failing and increased by 0.4 units in failing myocardium. For twitch force,
the [Ca2+]50% was increased 0.11 and 0.13 pCa units for non-failing and myopathic
myocardium, respectively. Interestingly, the Hill coefficient for twitch was decreased by
two units in nonfailing human myocardium, as opposed to only a 0.81 unit decrease in
myopathic myocardium [7]. These data indicate that not only are there differences at the
level of the thin myofilaments but that these differences may be reflected in changes in
myofilament calcium responsiveness ifchallenged with agents targeted to act at the level
ofthe thin myofilaments.
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A 25 percent decrease in myofibrillar ATPase activity has been reported in failing
hearts along with a 20 percent decrease in myofibrillar protein content in ischemic and
idiopathic dilated cardiomyopathy by two separate groups, as well as ourlaboratory (Liao,
unpublished data) [8, 9]. Ifin the presence ofan elevatedresting intracellular calcium con-
centration there was normal myofibrillar ATPase activity, the force-calcium relationship
would be shifted upward in the diastolic ranges, thereby reducing contractile reserve [12].
A lower MgATPase activity might, therefore, prove beneficial in the setting of heart fail-
ure where slower cross-bridge cycling rates have been reported as well as diminished sub-
strate availability for energy supply [10, 11].
Dynamic stiffness spectral analysis was performed on trabeculae carneae obtained
from non-failing hearts of brain-dead organ donors (n = 5), hearts ofpatients undergoing
surgery for mitral stenosis (n = 4) and patients with end-stage heart failure from dilated
cardiomyopathy (n = 6). The left ventricle from patients with mitral stenosis was assumed
normal because it is relatively protected, and patients demonstrated no change in left ven-
tricular function. As the length was oscillated sinusoidally, the force outputs were sinu-
soidal in all three groups. At low frequencies ofoscillations, the amplitude offorce oscil-
lation was constant in both non-failing and failing muscles. As the frequency increased,
the amplitude of force decreased and reached a minimum at about 0.78 + 0.06 Hz (n = 5)
for non-failing muscles, 0.51 + 0.09 (n = 4) for the mitral stenosis group (p = .036 com-
pared to controls) and 0.42 + 0.06 Hz (n =6) formyopathic muscles (p = .002, compared
to controls). Cross-bridge cycling rates for muscles from failing hearts and hearts with
mitral stenosis were not different (p = .4). Further increases in the frequency ofoscillation
resulted in a similar increase in stiffness for all experimental groups, which reached a
plateau above 30 Hz. This clearly shows that 1) the cross-bridge cycling rate in myopath-
ic muscles is reduced and 2) the number of force-generating cross-bridges is the same in
non-failing and myopathic hearts under ideal conditions of substrate and maximal calci-
um-activation. These findings also indicate that care should be exercised when comparing
samples from presumed "normal" or "control" hearts (i.e., mitral stenosis or patients with
coronary artery disease).
PEAK CYTOSOLIC [Ca2+]i, CALCIUM MOBILIZATION
AND CONTRACTILE ACTIVATION
As a result of the long-held belief that the major defect in heart failure is decreased
contractility, the pharmaceutical industry has focussed on the development ofagents that
increase [Ca2+]i and result in positive inotropy. However, the use ofpositive inotropes has
not proven to be a panacea. This has resulted in the formulation of the second corollary
that heart failure is an end-stage process that is not amenable to pharmacologic interven-
tion with regard to progression or reversal of the disease process. One of the first abnor-
malities detected in cardiac fibers from patients withend-stage heart failure was an abnor-
mal intracellular [Ca2+]i handling first reported by Gwathmey et al. [13]. The abnormali-
ty in myopathic muscles loaded with the bioluminescent photoprotein aequorin was char-
acterized by a prolonged [Ca2+]i transient with an additional[Ca2+], signal (L2). They also
found that diastolic [Ca2+]i was elevated in myopathic fibers whereas systolic [Ca2+]i was
unchanged at a time when there was an often blunted augmentation of peak contractile
force in failing myocardium compared to non-failing myocardium [14]. In contrast,
[Ca2+]. transients recorded from isolated single cells from failing hearts loaded with the
Ca2+ indicator fura-2 were found to have decreased systolic peak [Ca2+]i, but elevated
diastolic [Ca2+]1i [15]. However, Lederer et al. found that in isolated myocytes loaded with
the calcium indicator Indo peak [Ca2+]i attained during a 60 mV depolarization was -1
IM, similar to 1.2 IM seen in multicellular preparations stimulated at 0.33 Hz loaded
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Figure 6A (top three panels). Aequorin determined peak [Ca2+J1 in micomoles (iM) for twitch
in control and myopathic human myocardium in the presence of increasing [Ca2 ] in mil-
limolar (mM). Non-failing myocardium = open circles; failing myocardium = closec circles.
Figure 6B (bottom three panels). Peak [Ca2+J for steady-state tetanizations in the presence of
increasing [Ca2+10 in the absence of ryanodine.
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with aequorin [22]. Further, Lederer et al. [22] reported higher resting intracellular calci-
um concentrations with repetitive stimulations (-375 nM) similar to our findings in mul-
ticellular preparations. They proposed that the increase in contractile force was more dra-
matic than the increase in the amplitude ofthe [Ca2+]i transients that were superimposed
on a rising diastolic [Ca2+]i although there was progressive loading of the sarcoplasmic
reticulum. Also, Vahl et al. found that peak [Ca2+]i in fura-2 loaded trabeculae carneae
were similar for isometrically contracting non-failing and failing muscle preparations
[16]. With afterload reduction, there were, however, alterations in the shape of the calci-
um transient: the amplitude increased, the time to peak was delayed and at lower after-
loads, a long-lasting plateau was observed and the diastolic decay was slowed [16].
Demonstrated in Figure 6A is aequorin-determined peak [Ca2+]i for twitch in non-failing
(open circles) and failing human myocardium (closed circles) in the presence of increas-
ing [Ca2+]0. Pooling thedatarevealed nodifference in peak[Ca2+]i fortwitch.Also shown
in Figure 6B is peak [Ca2+]. for steady-state tetanizations in the presence of increasing
[Ca2+]O. Again, peak [Ca2+]i were similar for non-failing (open circles) and failing mus-
cles (closed circles). These data would suggest that failing human myocardium has suffi-
cient [Ca2+]i. We propose that failing myocardium should benefit from improvement in
calcium mobilization.
An important observation is that at lower stimulation rates and at 1 Hz at 35-370C,
there is no difference in peak contractile performance in failing and non-failing human
myocardium. Figure 7 shows the effect of increasing the temperature from 300C to 370C
on the calcium transient. This experiment demonstrates that the occurrence of the two
components in the calcium transient is not an artifact of the lower temperature at which
earlier aequorin experiments in failing human myocardium were performed [13]. These
data are further supported by a recent report in muscles from patients with hypertrophic
300C
Figure 7. Shows the effect of increasing the temperature from 300C to 370C in a muscle
demonstrating two components to the calcium transient. Upper trace denotes calcium transient.
Arrow denotes transient at 370C. Note the abbreviation in time course. The lower panel demon-
strates the effect ofincreasing temperature (370C) on isometric twitch force. Again note the abbre-
viation at the higher temperature (arrow).
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Figure 8. Upperpanels demonstrate calcium transients as detected with aequorin. Lower pan-
els demonstrate associated contractile force in isometrically contracting trabeculae carneae.
Using paired electrical stimulation in the case of control myocardium, there is an associated
decrease in the amplitude ofboth the calcium transient and force fortheextrasystole (ES). The post-
extrasystole (PES) is associated with greatercontractile force and alarger calcium transient. In myo-
pathic myocardium, a greater amplitude of the force of contraction was observed for the extrasys-
tole (ES). The amplitude ofthe first fast component ofthe [Ca2 ]. signal is greatly diminished com-
pared to the PES. There is a large increase in the amplitude ofthe second slower calcium transient
component (L2).
cardiomyopathy studied at 370C [17]. The observation of similar peak twitch force at
slower stimulation rates has been confirmed in numerous laboratories [18-21].
A potential greater dependency ofcontractile activation on the amplitude ofthe sec-
ond slower component as opposed to the fast first component is suggested in Figure 8.
Using paired electrical stimulation, which is similar to a premature contraction or
extrasystole with a postextrasystole, a greater amplitude of the force of contraction was
observed both for the post-extrasystole and extrasystole in failing myocardium. The
amplitude ofthe first fast component ofthe[Ca2+]i signal is greatly diminished in the case
of the extrasystole as opposed to the post-extrasystole, which is associated with greater
SRcalcium release. The second slower component, however, was significantly larger dur-
ing the extrasystole. It has been demonstrated that an increase in the amplitude of L2
results in potentiation of the extrasystole in myopathic muscles and most likely reflects
activation of the myofilaments by calcium [14]. In the case of non-failing myocardium,
there is an associated decrease in the amplitude of both the calcium transient and force
associated with the extrasystole. The post-extrasystole was associated with an increase in
SR calcium release and force.
AREAS OF CONTROVERSY
The appearance oftwo components seen in multicellular preparations has been found
by some investigators in isolated myocytes using the calcium indicator Fura-2 [23]. This
group reports similar peak SR calcium release concentrations as found in other species
including the dog and rat (RuthAltschuld, personal communication). However, there has
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been areport in isolated myocytes using the fluorescent indicatorFura-2 thatpeak SR cal-
cium release is diminished by about 50 percent [15]. The study with Fura-2 did not report
cell shortening nor force. This report, however, found a significant increase in resting cal-
cium concentration similar to earlier reports (172 percenthighercompared to 148 percent
higher in multicellular preparations using aequorin) [14]. As a result of the aforemen-
tioned data, the current debate would appear to be reduced to intracellular calcium abili-
ty because ofthe known relationship between calcium and force. There are, however, sev-
eral compelling lines ofevidence that suggest that intracellular calcium handling, though
in part responsible for contractile performance, cannot be the sole factor involved.
It was recently demonstrated in severely hypertrophied myocardium from patients
with hypertrophic cardiomyopathy that agents that increased intracellular calcium con-
centration further impaired systolic as well as diastolic performance [17]. This is similar
to findings in patients with end-stage heart failure due to ischemic cardiomyopathy and
idiopathic cardiomyopathy [23, 24]. However, agents that improved SR calcium mobi-
lization function prevented and/or improved the detrimental effect of increased intracel-
lular calcium concentration in the presence offrequency perturbation [17, 23, 24].
How do [Ca2+]i determinations fit with several other observations regarding calcium
channel number and function, and sarcoplasmic reticulum calcium release? Calcium
channel number has been reported to be increased in the setting of hypertrophic car-
diomyopathy [25], decreased [26] or unchanged in the setting of idiopathic dilated car-
diomyopathy and ischemic cardiomyopathy [20, 27]. The reported increase in calcium
channel number in hypertrophic cardiomyopathy might explain in part the reported nega-
tive inotropic effects of agents that increase transsarcolemmal calcium in flux, i.e.,
increased extracellular calcium concentration [17]. However, it would not support similar
observations in the presence ofdigitalis, an alkaloid that acts via an increase in intracel-
lular sodium and resultant sodium-calcium exchange. Therefore, a change in calcium
channel number may or may not contribute to reported differences in [Ca2+]i. In the case
of idiopathic dilated cardiomyopathy, the picture is less clear. There are reports that the
calcium channel number is reduced by 20 percent as detected with radioligand binding
studies or unchanged [20, 26, 27]. Associated with the observation ofa decrease in calci-
um channel number there was a 20 percent decrease in mRNA for the a-l subunit of the
dihydropyridine receptor subunit (Dr. James D. Marsh, personal communication). These
observations would suggest a reduced transsarcolemmal calcium flux with resultant
diminished SR calcium loading and/or release (e.g., calcium-induced calcium release).
Interestingly, despite reports of a reduced number of calcium channels, calcium channel
current density (ICa) has been demonstrated to be unchanged in myocytes isolated from
failing human hearts [28]. In fact, the ICa tended to be higher (ICa -4.7 + 2.7 vs. -3.8 + 1.2
pA/cm2 forfailing and non-failing, respectively), which would supportphysiology exper-
iments. The lack ofstatistical significance most likely reflects the rather large variance in
the myopathic fibers and relatively small number of non-failing myocytes studied.
Further, activation and inactivation of ICa were found to be similar to myocytes isolated
from non-failing human myocardium [28].
Atfasterstimulation rates, myopathic humanmyocardiumdemonstrates aprogressive
abbreviation in action potential duration and, thereby, may affect transsarcolemmal calci-
um flux via calcium channels as well as SR calcium release [14]. This observation has
been supported by a report that peak ICa decreases as the contractions increase with repet-
itive stimulation in isolated human myocytes from patients with heart failure [22]. The
effect ofincreasing stimulation rate on force and action potential configuration is demon-
strated in Figure 9. Notice that with progressive abbreviation in action potential duration
there is an increase in diastolic force and a decrease in peak twitch force in failing
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myocardium. The role of changes in calcium channel number and function in relation to
the contractile activation seen in the setting ofheart failure remains elusive.
With regard to sarcoplasmic reticulum calcium loading and release, the experimental
findings have similarly been varied. Movsesian et al. have reported that sarcoplasmic
reticulum (SR) sequestration in failing human myocardium is not different from non-fail-
ing myocardium [29]. Further, they suggest that phospholamban activity is not altered
[30]. In contradistinction to these experimental findings, SR mRNA levels for SR Ca2+
ATPase activity have been reported to be decreased [31]. Limas et al. report that SR func-
tion is decreased in the setting of failure (3.3 ± 0.6 vs. 6.5 ± 0.5 nmol Ca2+/mg/min, p <
.01) using a similar preparation as used by Movsesian [32]. It is important to note that
Limas et al. also reported significantly reduced calcium uptake by the sarcoplasmic retic-
ulum at 4 to 5 months post-transplantation (4.5 + 0.5 nmoles Ca2+/mg/min compared to
5.6 + 0.5 nmoles Ca2+/mg/min, p < .01) [33]. Statistical analysis, however, would indicate
that the post-transplantation and dilated cardiomyopathy sarcoplasmic reticulum defect is
the same (p = .25). This then raises the question of whether the reported decreases in sar-
coplasmic reticulum Ca2+ ATPase activity are causally related to the systolic contractile
failure seen with heart failure. The transplanted hearts for a similar reduction in SR calci-
um uptake activity were not in systolic failure. The observation ofreduced activity, how-
ever, would support observed impairment of diastolic relaxation seen in transplanted
hearts [33]. A 30 percent decrease in SR Ca2+ ATPase message (with no change in total
number ofpumps but a decrease in density) has been reported. It has been suggested that
these changes might contribute to the diastolic dysfunction seen in failing human
myocardium but would not support the idea of a significantly reduced calcium uptake or
release by the SR [34]. Interestingly, using hyperpermeable skinned fiber preparations it
has been demonstrated that the calcium sequestering ability ofmyocardium from patients
withend-stage heart failure is similarifnothigher(maximum Ca2+uptake atpCa7.0, 1.81
0.1 Hz 33 Hz IHz 1Hz 01 .
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Figure 9. Multicellular action potentials recorded in trabeculae carneae electrically stimulat-
ed from non-failing and failing human myocardium. The muscles were stimulated at increasing
rates (Hz). Upper panels are action potentials for both control and myopathic myocardium. Lower
panels are associated isometric twitches. Experiments were performed at 300C, pH = 7.4, [Ca2+]0 =
2.5 mM. Note the relatively rapid stabilization of action potential duration in the trabeculae from
the non-failing heart. This was associated with an increase in twitch force. In contrast, there is pro-
gressive abbreviation of action potential duration in the muscle from a failing heart. Instead of
increasing twitch force there was a decrease in peak twitch force and an increase in end-diastolic
force at the higher stimulation rate.
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and 2.68 nmol Ca2+ /mg fiber protein in non-failing and failing human myocardium,
respectively) than seen in non-failing myocardium [6]. There was no difference in the
extent (0.71 + 0.06 vs. 0.65 + 0.07 in DCM) and rate of caffeine-induced Ca2+ release
(0.08 + 0.03 vs. 0.06 + 0.01 in dilated cardiomyopathy [DCM]). These observations
would support findings ofsimilar SR calcium release [13, 16, 22], but would not support
other studies [35, 36].
How can one reconcile differences in experimental findings, and more importantly,
do the differences provide important insights into the pathophysiology and/or pathogene-
sis of heart failure? What do these differences tell us with regard to the study of human
heart failure, and is there functional importance associated with these observations? A
piece ofthe puzzle might lie in the observation that changes in the frequency of stimula-
tion alter the action potential duration with resultant graded and fluctuating SR calcium
release [14]. In addition, another piece of the puzzle may lie in the observations that
depending on the level ofdepolarization that SR calcium-release can vary in amount and
duration [22, 37]. Yet another piece of the puzzle may lie in our recent observations that
pharmacologic interventions may alter transmembrane signalling and calcium channel
number [38]. We have recently studied a model of idiopathic dilated cardiomyopathy in
the turkey poult that demonstrates similar pathophysiology as seen in human heart failure
and found calcium channel number to change in a complex manner (e.g., initial increase,
followed by a decrease and finally another increase) [39]. Although the changes in calci-
um channel number were large compared to experimental findings in human myocardi-
um, a functional significance was suggested by the experimental findings that the nifedip-
ine-contraction response relationship was shifted by 0.5 log units higher in hearts that
demonstrated an increased number of calcium channels. Similar functional experiments
have not been performed in failing human myocardium. Because our study was a longi-
tudinal study without pharmacologic intervention, it would appear that some of the dif-
ferences reported in human myocardium may reflect differences in stages and/or duration
?No-Co EXCHANGE ?Ca+2 ATPase
[Ca2+]
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tCa ' v F \+ L D~~~~~~LH
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Figure 10. Abnormalities in excitation-contraction coupling in human myopathic hearts. CK
= creatine kinase; LDH = lactate dehydrogenase; ICa = calcium current; SR Ca2+ ATPase = sar-
coplasmic reticulum calcium ATPase; Ca2+ ATPase = sarcolemmal calcium ATPase; t = increase;
I = decrease; - = no change.
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Figure 11. Force and [Ca2+]i transients recorded from aequorin-loaded trabeculae and fura-2
loaded cells ofnormal and myopathic hearts (by permission ofDr. Beuckelmann).
of disease (although all hearts are classified as demonstrating heart failure reflected in
reduced ejection fractions) and potential effects ofpharmacologic interventions.
THE RELATIONSHIP BETWEEN FORCE AND CALCIUM:
IMPLICATIONS FOR CONTRACTILE PERFORMANCE
Figure 10 illustrates the abnormalities in excitation-contraction coupling that have
been reported so far in myopathic hearts. Since different investigators using different
experimental procedures and calcium indicators have obtained contrasting results, intra-
cellular [Ca2+]i handling in heart failure remains a controversial issue. Gwathmey et al.
found that systolic [Ca2+]i transients in trabeculae carneae from patients with end-stage
heart failure were similar to that ofcontrol muscles [14]. They also observed an addition-
al calcium signal (L2) indicating aprolongation ofthe diastolic [Ca2+]i [13]. Beuckelmann
et al. found that in single cells, diastolic [Ca2+]i is higher in diseased cells similar to a
report by Gwathmey et al. [14, 15]. In contrast to Gwathmey's group, these investigators
found that peak [Ca2+]i was diminished in myopathic cells, leading Beuckelmann et al.
[15] to propose that theirresults may explain the depressed contractility in vivo in patients
with heart failure. This conclusion, however, implicitly implies that peak [Ca2+]i during a
twitch determines force development. However, only during steady-state activation, such
as in tetanizations or activations in skinned fibers, can the force-[Ca2+]i relationship truly
reflect myofilament responsiveness to Ca2+ [40].
Beuckelmann et al. [15] have demonstrated calcium transients with extremely long
time courses. In fact, these transients appear to plateau in a similar way to the second
slower component reported in aequorin loaded preparations and, therefore, might be
likened to steady-state tetanizations. Figure 11 shows [Ca2+]i transients recorded from
aequorin-loaded trabeculae and fura-2 loaded cells of non-failing and myopathic hearts.
Examining these transients by time-averaging the [Ca2+]i transient, /T J Ca(t).dt where X
represents the duration ofthe transient, we find that the calculated time-averaged calcium
is -600 nM in myopathic vs. -400 nM in isolated myocytes from non-failing hearts. This
calculation shows that there is no shortage of[Ca2+]i in myopathic hearts.
Similarly, the data can be viewed from the force production end. Total calcium
reported (resting plus peak plus one standard deviation) for isolated human myocytes
reported by Beuckelmann et al. [15] would be 1138 nM for control and 702 nM for myo-
pathic. If in vivo force-calcium relationships reflect more closely the intact steady-state
force calcium relationship, the difference in contractile activation would be 12 percent. In
tetanized preparations, the [Ca2+]50% for control and myopathic human myocardium is
0.56 + 0.05 vs. 0.54 + 0.09 jM for control and myopathic, respectively, with Hill
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coefficients of 5.21 + 0.2 vs. 5.61 + 0.6 [4, 7]. For skinned fiber preparations, the
[Ca2+]50% and Hill coefficients are 1.56 + 0.22 vs. 1.44 + 0.16 RM, and 2.05 + 0.33 vs 2.3
+ 0.23, respectively [4, 7]. Further, for twitch force, the [Ca2+]50% are 1 + 0.02 vs. 0.72 +
0.13 IM with Hill coefficients 5.2 + 0.08 vs. 4.57 + 0.21 for control and myopathic
myocardium, respectively [4, 7]. In this case, the difference between control and myo-
pathic force is 8 percent. Such a relationship between force and calcium would be partic-
ularly applicable in failing human myocardium where the "apparent" force-calcium rela-
tionship is leftward shifted [4]. Failing human myocardium has a slower cross-bridge
cycling rate [10] and differential effect of agents targeted at the level of the myofilaments
[4, 5, 7]. Recently, it has been demonstrated not only that failing human myocardium
undergoes changes in troponin T isoform content [41] but also troponin T isoforms affect
calcium sensitivity and cooperativity as well.
Recent results gathered in multicellular trabeculae carneae from failing human hearts
support this method of analysis of the relationship between peak force and calcium con-
centrations while raising new questions. Figure 12 shows the [Ca2+]i and force responses
of a left ventricular trabeculae carneae taken from a failing heart at 1.0 Hz and 1.5 Hz
electrical stimulation rates at 320C. With the increased stimulation rate, the systolic force
decreased. The [Ca2+]j response to an increased stimulation rate from 1 Hz to 1.5 Hz
demonstrated significant differences. The peak [Ca2+] level is diminished by more than 50
percent suggesting that the intracellular calcium level has dramatically been reduced.
However, in response to the frequency perturbation, the resting intracellular calcium con-
centration increased. Also similar to past findings, the configuration of the calcium
Figure 12. Calcium signals and isometric twitch at steady-state (1 Hz) and during transition
to a new steady-state at a higher stimulation rate (1.5 Hz). Notice the decrease in peak ampli-
tude of the calcium transient (noisy traces) reflecting predominantly SR calcium release as detect-
ed with aequorin (nA). Also note the increase in diastolic calcium concentrations as the frequency
of stimulation is increased. Bottom panels are calcium transients and twitch force (smooth traces)
superimposed at steady-state for Hz and 1.5 Hz.
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transient varied. The time-to-peak was shortened, while the time to 80 percent relaxation
was prolonged. By reviewing the transient, not as peaks or levels, butrather as an amount,
the data show that the relative amounts of [Ca2+]i only decreased by 17 percent, a mere
fraction of the noticeable 50 percent decrease in the peak of the calcium transient result-
ing in a 20 percentdecrease in the systolic twitch force. Taking each variation in force and
calcium into consideration, the data show that the force-time integral of the muscle only
decreased by seven percent.
ENERGY SUPPLY AND DEMAND
Myocardial enzyme activity analyzes have shown significant differences between
patients with angina (i.e., decreased lactate dehydrogenase activity) and those with nor-
mal coronary arteriograms [42]. Nascimben et al. have reported that creatine kinase activ-
ity, total creatine (creatine plus phosphocreatine) is significantly lower in ventricles from
failing human hearts when compared to non-failing control hearts [11]. In addition, there
is a higher content of MB creatine kinase that most likely reflects a response of the heart
to increased wall stress. Changes in creatine kinase might result in diminished energy sup-
ply to ATPases and ionic pumps as well as the myofilaments (e.g., myofibrillar and
myosin ATPase). Mitochondrial deletions have been reported in patients with idiopathic
dilated cardiomyopathy as well as myocardial enzyme changes in alcoholic cardiomy-
opathy [43, 44]. Therefore, a mismatch between energy supply and demand could result
at higher heart rates and increased workloads (e.g., increased wall stress and pharmaco-
logically induced increased inotrophy, as is often seen in heart failure). The combinations
of decreased energy reserves and abnormal calcium metabolism would contribute to the
systolic dysfunction seen in patients with heart failure.
CONCLUSIONS
It is important to note that ourearlierexperimental findings [13] have been confirmed
by others now studying human myocardium: i.e., similar levels of contractile force at
slower stimulation rates [18-21]; prolonged action potentials [23, 28]; diminished respon-
siveness to phosphodiesterase inhibitors and cyclic AMP concentrations [19]; negative
force interval relationship [21]; similar myofilament force-calcium relationships and abil-
ity to generate similar levels of force [6, 18-21]; and elevated resting calcium concentra-
tions[15, 22]. Discrepancies appear to arise as one becomes further removed from intact
functional physiology and, thereby, raises questions as to whether experiments done in
test tubes or under "standard" conditions truly reflect intact muscle physiology. We there-
fore propose that although investigators assume they are studying similar disease states
under similar conditions this may not be the case. Scientists in varying laboratories must
be willing to experimentally repeat protocols so as to verify or refute reports in the liter-
ature. In the case of heart failure, the quest for information is too important for experi-
menters to seek novelty with regard to experimental protocol and experimental findings.
For it may well be the novelty in experimental protocols that muddles the scientific liter-
ature with regard to scientific findings and, more importantly, data interpretation of the
pathophysiology and pathogenesis ofheart disease. A sharing of human heart samples as
well as a united effort must be made by scientists using multiple techniques and animal
models ifthe area ofscientific investigation into the potential treatment ofheart failure is
to move forward.
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